nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—Infarction—Ramipril—type 1 diabetes mellitus	0.0562	0.0879	CcSEcCtD
Tadalafil—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0309	0.0483	CcSEcCtD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS1—type 1 diabetes mellitus	0.0279	0.0799	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS1—type 1 diabetes mellitus	0.0248	0.0713	CbGpPWpGaD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS2—type 1 diabetes mellitus	0.0166	0.0477	CbGpPWpGaD
Tadalafil—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.0164	0.0256	CcSEcCtD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—type 1 diabetes mellitus	0.0148	0.0425	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—ITPR3—type 1 diabetes mellitus	0.0144	0.0414	CbGpPWpGaD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS3—type 1 diabetes mellitus	0.0134	0.0383	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—ITPR3—type 1 diabetes mellitus	0.0129	0.0369	CbGpPWpGaD
Tadalafil—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0128	0.02	CcSEcCtD
Tadalafil—Deafness—Ramipril—type 1 diabetes mellitus	0.0127	0.0198	CcSEcCtD
Tadalafil—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.0124	0.0194	CcSEcCtD
Tadalafil—Amnesia—Ramipril—type 1 diabetes mellitus	0.0121	0.0188	CcSEcCtD
Tadalafil—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.012	0.0188	CcSEcCtD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS3—type 1 diabetes mellitus	0.0119	0.0342	CbGpPWpGaD
Tadalafil—Renal impairment—Ramipril—type 1 diabetes mellitus	0.0119	0.0186	CcSEcCtD
Tadalafil—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.0116	0.0181	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS1—type 1 diabetes mellitus	0.0109	0.0311	CbGpPWpGaD
Tadalafil—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.0105	0.0163	CcSEcCtD
Tadalafil—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0103	0.0162	CcSEcCtD
Tadalafil—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.0103	0.0162	CcSEcCtD
Tadalafil—Breast disorder—Ramipril—type 1 diabetes mellitus	0.0102	0.016	CcSEcCtD
Tadalafil—Gastritis—Ramipril—type 1 diabetes mellitus	0.01	0.0157	CcSEcCtD
Tadalafil—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00979	0.0153	CcSEcCtD
Tadalafil—Influenza—Ramipril—type 1 diabetes mellitus	0.00979	0.0153	CcSEcCtD
Tadalafil—PDE5A—Platelet homeostasis—NOS1—type 1 diabetes mellitus	0.00967	0.0278	CbGpPWpGaD
Tadalafil—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00954	0.0149	CcSEcCtD
Tadalafil—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00942	0.0147	CcSEcCtD
Tadalafil—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00939	0.0147	CcSEcCtD
Tadalafil—PDE11A—G alpha (s) signalling events—IAPP—type 1 diabetes mellitus	0.00931	0.0267	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SIRPG—type 1 diabetes mellitus	0.00922	0.0265	CbGpPWpGaD
Tadalafil—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0091	0.0142	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00866	0.0135	CcSEcCtD
Tadalafil—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00861	0.0135	CcSEcCtD
Tadalafil—Renal failure—Ramipril—type 1 diabetes mellitus	0.00858	0.0134	CcSEcCtD
Tadalafil—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00856	0.0134	CcSEcCtD
Tadalafil—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00849	0.0133	CcSEcCtD
Tadalafil—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00849	0.0133	CcSEcCtD
Tadalafil—Sweating—Ramipril—type 1 diabetes mellitus	0.00837	0.0131	CcSEcCtD
Tadalafil—PDE5A—penis—type 1 diabetes mellitus	0.00831	0.714	CbGeAlD
Tadalafil—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00823	0.0129	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—SIRPG—type 1 diabetes mellitus	0.00822	0.0236	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—ADRB1—type 1 diabetes mellitus	0.00814	0.0233	CbGpPWpGaD
Tadalafil—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00772	0.0121	CcSEcCtD
Tadalafil—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.0077	0.012	CcSEcCtD
Tadalafil—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00741	0.0116	CcSEcCtD
Tadalafil—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00731	0.0114	CcSEcCtD
Tadalafil—PDE11A—G alpha (s) signalling events—GCG—type 1 diabetes mellitus	0.00729	0.0209	CbGpPWpGaD
Tadalafil—Flushing—Ramipril—type 1 diabetes mellitus	0.00727	0.0114	CcSEcCtD
Tadalafil—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00708	0.0111	CcSEcCtD
Tadalafil—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00706	0.011	CcSEcCtD
Tadalafil—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00687	0.0107	CcSEcCtD
Tadalafil—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00656	0.0103	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS2—type 1 diabetes mellitus	0.00647	0.0186	CbGpPWpGaD
Tadalafil—Angioedema—Ramipril—type 1 diabetes mellitus	0.00623	0.00974	CcSEcCtD
Tadalafil—Vertigo—Ramipril—type 1 diabetes mellitus	0.00613	0.00958	CcSEcCtD
Tadalafil—Syncope—Ramipril—type 1 diabetes mellitus	0.00612	0.00956	CcSEcCtD
Tadalafil—Palpitations—Ramipril—type 1 diabetes mellitus	0.00603	0.00942	CcSEcCtD
Tadalafil—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.006	0.00937	CcSEcCtD
Tadalafil—Cough—Ramipril—type 1 diabetes mellitus	0.00595	0.00931	CcSEcCtD
Tadalafil—Convulsion—Ramipril—type 1 diabetes mellitus	0.00591	0.00924	CcSEcCtD
Tadalafil—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00581	0.00908	CcSEcCtD
Tadalafil—Chest pain—Ramipril—type 1 diabetes mellitus	0.00581	0.00908	CcSEcCtD
Tadalafil—Myalgia—Ramipril—type 1 diabetes mellitus	0.00581	0.00908	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00577	0.00902	CcSEcCtD
Tadalafil—PDE5A—Platelet homeostasis—NOS2—type 1 diabetes mellitus	0.00577	0.0165	CbGpPWpGaD
Tadalafil—Discomfort—Ramipril—type 1 diabetes mellitus	0.00574	0.00897	CcSEcCtD
Tadalafil—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00568	0.00888	CcSEcCtD
Tadalafil—Oedema—Ramipril—type 1 diabetes mellitus	0.00557	0.0087	CcSEcCtD
Tadalafil—Shock—Ramipril—type 1 diabetes mellitus	0.00548	0.00856	CcSEcCtD
Tadalafil—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00546	0.00853	CcSEcCtD
Tadalafil—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00543	0.00849	CcSEcCtD
Tadalafil—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00541	0.00845	CcSEcCtD
Tadalafil—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00538	0.00841	CcSEcCtD
Tadalafil—Hypotension—Ramipril—type 1 diabetes mellitus	0.0052	0.00813	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS3—type 1 diabetes mellitus	0.0052	0.0149	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00507	0.00793	CcSEcCtD
Tadalafil—Insomnia—Ramipril—type 1 diabetes mellitus	0.00504	0.00787	CcSEcCtD
Tadalafil—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.005	0.00781	CcSEcCtD
Tadalafil—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00496	0.00776	CcSEcCtD
Tadalafil—Somnolence—Ramipril—type 1 diabetes mellitus	0.00495	0.00774	CcSEcCtD
Tadalafil—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.0049	0.00766	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00481	0.00751	CcSEcCtD
Tadalafil—Fatigue—Ramipril—type 1 diabetes mellitus	0.0048	0.0075	CcSEcCtD
Tadalafil—Constipation—Ramipril—type 1 diabetes mellitus	0.00476	0.00744	CcSEcCtD
Tadalafil—PDE5A—Platelet homeostasis—NOS3—type 1 diabetes mellitus	0.00464	0.0133	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00455	0.00712	CcSEcCtD
Tadalafil—Urticaria—Ramipril—type 1 diabetes mellitus	0.00442	0.00691	CcSEcCtD
Tadalafil—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.0044	0.00688	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—SELL—type 1 diabetes mellitus	0.00412	0.0118	CbGpPWpGaD
Tadalafil—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.0041	0.00641	CcSEcCtD
Tadalafil—Asthenia—Ramipril—type 1 diabetes mellitus	0.00399	0.00624	CcSEcCtD
Tadalafil—Pruritus—Ramipril—type 1 diabetes mellitus	0.00394	0.00616	CcSEcCtD
Tadalafil—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00381	0.00595	CcSEcCtD
Tadalafil—Dizziness—Ramipril—type 1 diabetes mellitus	0.00368	0.00575	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—SELL—type 1 diabetes mellitus	0.00367	0.0105	CbGpPWpGaD
Tadalafil—Vomiting—Ramipril—type 1 diabetes mellitus	0.00354	0.00553	CcSEcCtD
Tadalafil—Rash—Ramipril—type 1 diabetes mellitus	0.00351	0.00549	CcSEcCtD
Tadalafil—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00351	0.00548	CcSEcCtD
Tadalafil—Headache—Ramipril—type 1 diabetes mellitus	0.00349	0.00545	CcSEcCtD
Tadalafil—Nausea—Ramipril—type 1 diabetes mellitus	0.00331	0.00517	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—ITPR3—type 1 diabetes mellitus	0.00323	0.00927	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SH2B3—type 1 diabetes mellitus	0.00304	0.00873	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ITPR3—type 1 diabetes mellitus	0.00288	0.00826	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SH2B3—type 1 diabetes mellitus	0.00271	0.00778	CbGpPWpGaD
Tadalafil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00245	0.00704	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00245	0.00702	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS1—type 1 diabetes mellitus	0.00243	0.00698	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00242	0.00694	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PRKCQ—type 1 diabetes mellitus	0.00228	0.00653	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00228	0.00653	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00222	0.00638	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VAV1—type 1 diabetes mellitus	0.00221	0.00634	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.0022	0.0063	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.0022	0.0063	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS1—type 1 diabetes mellitus	0.00217	0.00622	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00207	0.00593	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00204	0.00586	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PRKCQ—type 1 diabetes mellitus	0.00203	0.00582	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IGF2—type 1 diabetes mellitus	0.002	0.00574	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VAV1—type 1 diabetes mellitus	0.00197	0.00565	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00191	0.00548	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00185	0.00532	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IGF2—type 1 diabetes mellitus	0.00178	0.00512	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00173	0.00498	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IL2RA—type 1 diabetes mellitus	0.00169	0.00484	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00168	0.00481	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00167	0.00479	CbGpPWpGaD
Tadalafil—PDE5A—retina—type 1 diabetes mellitus	0.00158	0.136	CbGeAlD
Tadalafil—PDE11A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00152	0.00437	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00152	0.00435	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL2RA—type 1 diabetes mellitus	0.0015	0.00431	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00149	0.00429	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS2—type 1 diabetes mellitus	0.00145	0.00416	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00144	0.00413	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00141	0.00404	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.0014	0.00401	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00139	0.004	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00136	0.00389	CbGpPWpGaD
Tadalafil—PDE5A—cardiovascular system—type 1 diabetes mellitus	0.00134	0.115	CbGeAlD
Tadalafil—PDE11A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00131	0.00377	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00131	0.00375	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.0013	0.00372	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.0013	0.00372	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS2—type 1 diabetes mellitus	0.00129	0.00371	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IGF1—type 1 diabetes mellitus	0.00129	0.00369	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00127	0.00364	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00127	0.00363	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00122	0.0035	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ALB—type 1 diabetes mellitus	0.00122	0.0035	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS3—type 1 diabetes mellitus	0.00117	0.00334	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IGF1—type 1 diabetes mellitus	0.00115	0.00329	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.00114	0.00327	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.0011	0.00314	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ALB—type 1 diabetes mellitus	0.00109	0.00312	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00108	0.0031	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00107	0.00306	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS3—type 1 diabetes mellitus	0.00104	0.00298	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00103	0.00296	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00102	0.00294	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00102	0.00294	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IL2—type 1 diabetes mellitus	0.000988	0.00283	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000982	0.00282	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000967	0.00278	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SST—type 1 diabetes mellitus	0.0009	0.00258	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000896	0.00257	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL2—type 1 diabetes mellitus	0.000881	0.00253	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000802	0.0023	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000772	0.00221	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00075	0.00215	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000748	0.00214	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000682	0.00196	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000679	0.00195	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000654	0.00188	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000624	0.00179	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00062	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00059	0.00169	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000589	0.00169	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00058	0.00166	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000571	0.00164	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000567	0.00163	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000477	0.00137	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000451	0.00129	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000436	0.00125	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000434	0.00124	CbGpPWpGaD
Tadalafil—CYP3A4—kidney—type 1 diabetes mellitus	0.000408	0.035	CbGeAlD
Tadalafil—PDE11A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000403	0.00115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000395	0.00113	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000336	0.000963	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000335	0.000961	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000333	0.000956	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000282	0.000809	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000256	0.000735	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000201	0.000578	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000197	0.000565	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000189	0.000543	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000164	0.000471	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00013	0.000372	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	0.00011	0.000314	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	0.000103	0.000296	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	0.000102	0.000294	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	0.000101	0.000289	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	8.02e-05	0.00023	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	6.79e-05	0.000195	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	4.51e-05	0.000129	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	4.13e-05	0.000119	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.95e-05	0.000113	CbGpPWpGaD
